A Study to Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial Fibrillation

NCT05804747 · clinicaltrials.gov ↗

COMPLETED

Status

1204

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Edoxaban

Sponsor

Daiichi Sankyo

Collaborators

[object Object]